Patent ID: 9067988
Filing Date: 2015-06-30
Classification: A61K,C07K

Abstract:
1. A method of treating pain or eliciting an analgesic effect in an individual, comprising administering an effective amount of at least one anti-human NGF antibody or fragment thereof, wherein the anti-NGF antibody comprises the light chain complementarity determining region (CDR)1 of SEQ ID NO:15, the light chain CDR2 of SEQ ID NO:16, the light chain CDR3 of SEQ ID NO:17, the heavy chain CDR1 of SEQ ID NO:18, the heavy chain CDR2 of SEQ ID NO:19, and the heavy chain CDR3 of SEQ ID NO:20, or an antibody or antibody fragment that competes with any of the foregoing antibodies, and/or an antibody or antibody fragment that binds to the same or overlapping epitope as any of the foregoing antibodies.